Literature DB >> 34345020

New treatments for amyloidosis.

Sarah Onuora1.   

Abstract

Entities:  

Year:  2021        PMID: 34345020     DOI: 10.1038/s41584-021-00680-5

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Ed Gane; Jorg Taubel; Justin Kao; Marianna Fontana; Michael L Maitland; Jessica Seitzer; Daniel O'Connell; Kathryn R Walsh; Kristy Wood; Jonathan Phillips; Yuanxin Xu; Adam Amaral; Adam P Boyd; Jeffrey E Cehelsky; Mark D McKee; Andrew Schiermeier; Olivier Harari; Andrew Murphy; Christos A Kyratsous; Brian Zambrowicz; Randy Soltys; David E Gutstein; John Leonard; Laura Sepp-Lorenzino; David Lebwohl
Journal:  N Engl J Med       Date:  2021-06-26       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.